Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
NCT02873468
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
116
Enrollment
INDUSTRY
Sponsor class
Conditions
Eosinophilic Esophagitis
Interventions
DRUG:
Florence 30 μg/mL
DRUG:
Florence 60 μg/mL
DRUG:
Florence 90 μg/mL
OTHER:
Placebo
Sponsor
EMS